High Peak, United Kingdom

Matthew John Tozer


 

Average Co-Inventor Count = 8.0

ph-index = 6

Forward Citations = 58(Granted Patents)


Location History:

  • Chapel-en-le-Frith, GB (2015)
  • High Peak, GB (2012 - 2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Matthew John Tozer: Innovating Therapeutic Compounds for Inflammatory Disorders

Introduction

Matthew John Tozer, an accomplished inventor based in High Peak, Great Britain, is known for his significant contributions to the field of therapeutic compounds. With a remarkable portfolio of six patents, Tozer has dedicated his work to developing treatments for a range of inflammatory and autoimmune disorders, demonstrating a commitment to advancing medical science for the benefit of patients worldwide.

Latest Patents

Among his latest innovations are the aryl-phenyl-sulfonamido-cycloalkyl compounds, collectively referred to as 'APSAC compounds.' These novel compounds are designed to provide therapeutic solutions for various inflammatory conditions, including, but not limited to, rheumatoid arthritis, psoriasis, chronic obstructive pulmonary disease (COPD), and atherosclerosis. Furthermore, they hold potential in addressing disorders related to bone loss, such as osteoporosis and can be used in cancer treatments, targeting both hematological malignancies and solid tumors. The pharmaceutical compositions incorporating these APSAC compounds promise to transform therapeutic approaches in treating inflammation and immune-mediated disorders, thereby enhancing patient care and quality of life.

Career Highlights

Matthew is currently associated with Pimco 2664 Limited, where he continues to pioneer innovative solutions in therapeutic developments. His expertise and dedication have set a benchmark in the industry, propelling advancements that are essential for effective treatments of complex medical conditions.

Collaborations

Within his professional journey, Matthew has collaborated with other notable experts like Iain Robert Greig and Rose Mary Sheridan. These partnerships highlight the collaborative nature of scientific research, allowing for the sharing of ideas and fostering innovation that can lead to groundbreaking discoveries in medicine.

Conclusion

In summary, Matthew John Tozer exemplifies the spirit of innovation within the realm of therapeutic compounds. His patents, particularly the APSAC compounds, represent a significant stride in treating challenging health issues, underlining his role as a key inventor in the field. His ongoing work at Pimco 2664 Limited, alongside esteemed colleagues, continues to pave the way for future advancements in medical research and therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…